Works matching AU Tiong, S.


Results: 43
    1
    2
    3
    4

    Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer.

    Published in:
    Cancer Science, 2020, v. 111, n. 2, p. 561, doi. 10.1111/cas.14260
    By:
    • Takeuchi, Shinji;
    • Hase, Tetsunari;
    • Shimizu, Shinobu;
    • Ando, Masahiko;
    • Hata, Akito;
    • Murakami, Haruyasu;
    • Kawakami, Takahiro;
    • Nagase, Katsuhiko;
    • Yoshimura, Kenichi;
    • Fujiwara, Tadami;
    • Tanimoto, Azusa;
    • Nishiyama, Akihiro;
    • Arai, Sachiko;
    • Fukuda, Koji;
    • Katakami, Nobuyuki;
    • Takahashi, Toshiaki;
    • Hasegawa, Yoshinori;
    • Ko, Tun Kiat;
    • Ong, S. Tiong;
    • Yano, Seiji
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1902, doi. 10.1007/s00259-019-04389-2
    By:
    • Goncalves, Isaac;
    • Burbury, Kate;
    • Michael, Michael;
    • Iravani, Amir;
    • Ravi Kumar, Aravind S.;
    • Akhurst, Tim;
    • Tiong, Ing S.;
    • Blombery, Piers;
    • Hofman, Michael S.;
    • Westerman, David;
    • Hicks, Rodney J.;
    • Kong, Grace
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor.

    Published in:
    Nature Medicine, 2010, v. 16, n. 2, p. 205, doi. 10.1038/nm.2091
    By:
    • Janes, Matthew R.;
    • Limon, Jose J.;
    • So, Lomon;
    • Jing Chen;
    • Lim, Raymond J.;
    • Chavez, Melissa A.;
    • Vu, Collin;
    • Lilly, Michael B.;
    • Mallya, Sharmila;
    • Ong, S. Tiong;
    • Konopleva, Marina;
    • Martin, Michael B.;
    • Ren, Pingda;
    • Yi Liu;
    • Rommel, Christian;
    • Fruman, David A.
    Publication type:
    Article
    34

    Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 6, p. 1026, doi. 10.1111/bjh.16722
    By:
    • Tiong, Ing S.;
    • Dillon, Richard;
    • Ivey, Adam;
    • Teh, Tse‐Chieh;
    • Nguyen, Phillip;
    • Cummings, Nicholas;
    • Taussig, David C.;
    • Latif, Annie‐Louise;
    • Potter, Nicola E.;
    • Runglall, Manohursingh;
    • Russell, Nigel H.;
    • Raj, Kavita;
    • Schwarer, Anthony P.;
    • Fong, Chun Yew;
    • Grigg, Andrew P.;
    • Wei, Andrew H.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43